Cargando…
Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea
Influenza is a communicable disease with most of the mortality burden falling on high-risk populations and those with pre-existing comorbidities and chronic diseases. In South Korea, adults aged 50–64 years are recommended for influenza vaccination, but no government financial support is offered to...
Autores principales: | Jang, Hyeongap, Kim, Joon Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605866/ https://www.ncbi.nlm.nih.gov/pubmed/30550365 http://dx.doi.org/10.1080/21645515.2018.1556075 |
Ejemplares similares
-
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
por: Choi, Min Joo, et al.
Publicado: (2022) -
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
por: Kim, Yun-Kyung, et al.
Publicado: (2018) -
Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age
por: Poder, Airi, et al.
Publicado: (2023) -
Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia
por: Moa, Aye M., et al.
Publicado: (2021) -
The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom
por: Kohli, Michele A., et al.
Publicado: (2021)